ABCC11/MRP8 confers pemetrexed resistance in lung cancer

Cancer Science

Volumn 101, Issue 11, 2010, Pages 2404-2410

  Uemura, Takehiro ^a   Oguri, Tetsuya ^a   Ozasa, Hiroaki ^a   Takakuwa, Osamu ^a   Miyazaki, Mikinori ^a   Maeno, Ken ^a   Sato, Shigeki ^a   Ueda, Ryuzo ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ABC BINDING CASSETTE TRANSPORTER C11; ABC TRANSPORTER; METHOTREXATE; PEMETREXED; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CARCINOMA CELL; CONTROLLED STUDY; CROSS RESISTANCE; DRUG ACCUMULATION; DRUG CYTOTOXICITY; DRUG TRANSPORT; GENE EXPRESSION; GENOTYPE; HUMAN; HUMAN CELL; IC 50; LUNG CANCER; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADENOCARCINOMA; ANTIMETABOLITES, ANTINEOPLASTIC; ATP-BINDING CASSETTE TRANSPORTERS; BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL SURVIVAL; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE FREQUENCY; GENOTYPE; HUMANS; INHIBITORY CONCENTRATION 50; LUNG NEOPLASMS; METHOTREXATE; POLYMORPHISM, SINGLE NUCLEOTIDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR MARKERS, BIOLOGICAL;

EID: 78049426102     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2010.01690.x     Document Type: Article

References (32)

1. Farber S, Diamond LK. Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid. N Engl J Med 1948; 238: 787-93.
2. Chen MJ, Shimada T, Moulton AD et al. The functional human dihydrofolate reductase gene. J Biol Chem 1984; 259: 3933-43.
3. Vogelzang NJ, Rusthoven JJ, Symanowski J et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 2003; 21: 2636-44.
4. Scagliotti GV, Parikh P, Von Pawel J et al. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol 2008; 26: 3543-51.
5. Shih C, Chen VJ, Gossett LS et al. LY231514, a pyrrolo[2, 3-d]pyrimidine-based antifolate that inhibits multiple folate-requiring enzymes. Cancer Res 1997; 57: 1116-23.
6. Shih C, Habeck LL, Mendelsohn LG, Chen VJ, Schultz RM. Multiple folate enzyme inhibition: mechanism of a novel pyrrolopyrimidine-based antifolate LY231514 (MTA). Adv Enzyme Regul 1998; 38: 135-52.
7. Ozasa H, Oguri T, Uemura T et al. Significance of thymidylate synthase for resistance to pemetrexed in lung cancer. Cancer Sci 2009; 101: 161-6.
8. Hooijberg JH, De Vries NA, Kaspers GJ, Pieters R, Jansen G, Peters GJ. Multidrug resistance proteins and folate supplementation: therapeutic implications for antifolates and other classes of drugs in cancer treatment. Cancer Chemother Pharmacol 2006; 58: 1-12.
9. Guo Y, Kotova E, Chen ZS et al. MRP8, ATP-binding cassette C11 (ABCC11), is a cyclic nucleotide efflux pump and a resistance factor for fluoropyrimidines 2', 3'-dideoxycytidine and 9'-(2'-phosphonyl-methoxyethyl)adenine. J Biol Chem 2003; 278: 29509-14.
10. Chen ZS, Robey RW, Belinsky MG et al. Transport of methotrexate, methotrexate polyglutamates, and 17beta-estradiol 17-(beta-D-glucuronide) by ABCG2: effects of acquired mutations at R482 on methotrexate transport. Cancer Res 2003; 63: 4048-54.
11. Pesce MA, Bodourian SH. Evaluation of a fluorescence polarization immunoassay procedure for quantitation of methotrexate. Ther Drug Monit 1986; 8: 115-21.
12. Chen ZS, Guo Y, Belinsky MG, Kotova E, Kruh GD. Transport of bile acids, sulfated steroids, estradiol 17-beta-D-glucuronide, and leukotriene C4 by human multidrug resistance protein 8 (ABCC11). Mol Pharmacol 2005; 67: 545-57.
13. Yoshiura K, Kinoshita A, Ishida T et al. A SNP in the ABCC11 gene is the determinant of human earwax type. Nat Genet 2006; 38: 324-30.
14. Toyoda Y, Sakurai A, Mitani Y et al. Earwax, osmidrosis, and breast cancer: why does one SNP (538G>A) in the human ABC transporter ABCC11 gene determine earwax type? FASEB J 2009; 23: 2001-13.
15. Klein I, Sarkadi B, Váradi A. An inventory of the human ABC proteins. Biochim Biophys Acta 1999; 1461: 237-62.
16. Bryan J, Aguilar-Bryan L. The ABCs of ATP-sensitive potassium channels: more pieces of the puzzle. Curr Opin Cell Biol 1997; 9: 553-9.
17. Haimeur A, Conseil G, Deeley RG, Cole SP. The MRP-related and BCRP/ABCG2 multidrug resistance proteins: biology, substrate specificity and regulation. Curr Drug Metab 2004; 5: 21-53.
18. Yabuuchi H, Shimizu H, Takayanagi S, Ishikawa T. Multiple splicing variants of two new human ATP-binding cassette transporters, ABCC11 and ABCC12. Biochem Biophys Res Commun 2001; 288: 933-9.
19. Bera TK, Lee S, Salvatore G, Lee B, Pastan I. MRP8, a new member of ABC transporter superfamily, identified by EST database mining and gene prediction program, is highly expressed in breast cancer. Mol Med 2001; 7: 509-16.
20. Tammur J, Prades C, Arnould I et al. Two new genes from the human ATP-binding cassette transporter superfamily, ABCC11 and ABCC12, tandemly duplicated on chromosome 16q12. Gene 2001; 273: 89-96.
21. Oguri T, Bessho Y, Achiwa H et al. MRP8/ABCC11 directly confers resistance to 5-fluorouracil. Mol Cancer Ther 2007; 6: 122-7.
22. Ceppi P, Volante M, Saviozzi S et al. Squamous cell carcinoma of the lung compared with other histotypes shows higher messenger RNA and protein levels for thymidylate synthase. Cancer 2006; 107: 1589-96.
23. Assaraf YG. The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis. Drug Resist Updat 2006; 9: 227-46.
24. Wielinga P, Hooijberg JH, Gunnarsdottir S et al. The human multidrug resistance protein MRP5 transports folates and can mediate cellular resistance against antifolates. Cancer Res 2005; 65: 4425-30.
25. Volk EL, Schneider E. Wild-type breast cancer resistance protein (BCRP/ABCG2) is a methotrexate polyglutamate transporter. Cancer Res 2003; 63: 5538-43.
26. Spinella MJ, Brigle KE, Freemantle SJ, Sierra EE, Goldman ID. Comparison of methotrexate polyglutamylation in L1210 leukemia cells when influx is mediated by the reduced folate carrier or the folate receptor Lack of evidence for influx route-specific effects. Biochem Pharmacol 1996; 52: 703-12.
27. Miura K, Yoshiura K, Miura S et al. A strong association between human earwax-type and apocrine colostrum secretion from the mammary gland. Hum Genet 2007; 121: 631-3.
28. Yoo WM, Pae NS, Lee SJ, Roh TS, Chung S, Tark KC. Endoscopy-assisted ultrasonic surgical aspiration of axillary osmidrosis: a retrospective review of 896 consecutive patients from 1998 to 2004. J Plast Reconstr Aethet Surg 2006; 59: 978-82.
29. Petrakis NL. Cerumen phenotype and epithelial dysplasia in nipple aspirates of breast fluid. Am J Phys Anthropol 1983; 62: 115-8.
30. Petrakis NL. Cerumen genetics and human breast cancer. Science 1971; 173: 347-9.
31. Orlando M, Lee JS, Yang C et al. Efficacy of pemetrexed-cisplatin (PC) in East Asian patients: subgroup analysis of a phase III study comparing PC vs gemcitabine-cisplatin (GC) in first-line treatment of advanced non-small cell lung cancer (NSCLC). J Clin Oncol 2009; 27(15 Suppl): A8045.
32. Cusatis G, Gregorc V, Li J et al. Pharmacogenetics of ABCG2 and adverse reactions to gefitinib. J Natl Cancer Inst 2006; 98: 1739-42.